Back to Search
JEFFREY HALLER, MD
MD
Family Medicine Physician
NPI: 1659467629IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
055826(GA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
PMID 19259645·Psychopharmacology (Berl)·2009
4-observational
The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
PMID 18054070·Front Neuroendocrinol·2008
6-review
Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.
PMID 17445240·Eur J Neurosci·2007
7-preclinical
The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats.
PMID 16893596·Prog Neuropsychopharmacol Biol Psychiatry·2007
7-preclinical
Patterns of violent aggression-induced brain c-fos expression in male mice selected for aggressiveness.
PMID 16687160·Physiol Behav·2006
4-observational
Normal and abnormal aggression: human disorders and novel laboratory models.
PMID 16483889·Neurosci Biobehav Rev·2006
6-review
Mechanisms differentiating normal from abnormal aggression: glucocorticoids and serotonin.
PMID 16280125·Eur J Pharmacol·2005
6-review
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.
PMID 16148446·Behav Pharmacol·2005
4-observational
The activation of raphe serotonergic neurons in normal and hypoarousal-driven aggression: a double labeling study in rats.
PMID 15904714·Behav Brain Res·2005
4-observational
Psychosocial conditions and the efficacy of clinically available anxiolytics.
PMID 15473255·Curr Drug Targets·2004
6-review
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
PMID 15252281·Behav Pharmacol·2004
4-observational
Chronic glucocorticoid deficiency-induced abnormal aggression, autonomic hypoarousal, and social deficit in rats.
PMID 15189330·J Neuroendocrinol·2004
7-preclinical
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.
PMID 15078564·Eur J Neurosci·2004
4-observational
Social instability in female rats: effects on anxiety and buspirone efficacy.
PMID 14760513·Psychopharmacology (Berl)·2004
7-preclinical
Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety.
PMID 14501256·Behav Pharmacol·2003
7-preclinical
Stress-induced social avoidance: a new model of stress-induced anxiety?
PMID 12419409·Physiol Behav·2002
7-preclinical
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
PMID 12405999·Eur J Neurosci·2002
7-preclinical
Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression.
PMID 12128153·Brain Res Bull·2002
7-preclinical
The effect of glucocorticoids on the anxiolytic efficacy of buspirone.
PMID 11605098·Psychopharmacology (Berl)·2001
7-preclinical
The link between stress and the efficacy of anxiolytics. A new avenue of research.
PMID 11438359·Physiol Behav·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 104 PROMINENCE POINT PKWY, SUITE 104
CANTON, GA 30114 - Phone
- (770) 704-6988
Quick Facts
- NPI
- 1659467629
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile